Press

Kortex on the media

Global Venturing

With three health corporate LPs in tow, Kortex Ventures’ focus is digital and personalised. Can one strategic venture unit really serve three different corporations and do them each justice? This is the question that Kortex Ventures, which invests on behalf of medical diagnostics companies Fleury and Sabin as well as investor Bradesco Saude, is trying to figure out.

View more (original in Portuguese)

Isto É

This Wednesday, Fleury announced the creation of an investment fund of up to BRL 200 million in a partnership with Grupo Sabin. The target is startups focused on digital health, diagnostics, and personalized medicine...

View more (original in Portuguese)

MedicinaSA

Grupo Fleury and Grupo Sabin announced the creation of Kortex, a Corporate Venture Capital (CVC) that aims to act as an information hub, identifying opportunities in the market, analyzing, and...

View more (original in Portuguese)

Valor Investe

Cade (the Brazilian regulatory agency) approved the creation of Kortex Ventures fund by Fleury and Sabin laboratories...

View more (original in Portuguese)